On April 2, 2026, Advanced Biomed Inc. announced its entry into a Share Purchase Agreement to acquire Acellent Technologies (Hong Kong) Co. Limited. The acquisition involves the purchase of 100% of the equity interest in Acellent Technologies for a total of 270,000 shares of Advanced Biomed's common stock, valued at approximately $1,080,000. This strategic move is expected to enhance Advanced Biomed's capabilities in providing AI-powered financial verification and audit solutions, aligning with its growth strategy in the technology sector. The transaction is contingent upon the completion of financial and legal due diligence and obtaining necessary regulatory approvals. The acquisition reflects Advanced Biomed's commitment to expanding its operational footprint and enhancing its service offerings in the rapidly evolving tech landscape.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.